SS
GOSS icon

SBI Securities’s Gossamer Bio GOSS Stock Holding History

SBI Securities’s Portfolio GOSS Stock Details GOSS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$101 Hold
614
– – ﹤0.01% 3507
2026
Q1 		$202 Sell
614
-3,786
-86% -$5.95K ﹤0.01% 3212
2025
Q4 		$13.6K Sell
4,400
-796
-15% -$2.27K ﹤0.01% 1591
2025
Q3 		$13.7K Buy
5,196
+4,243
+445% +$9.35K ﹤0.01% 1613
2025
Q2 		$1.17K Sell
953
-158
-14% -$172 ﹤0.01% 2616
2025
Q1 		$1.22K Sell
1,111
-8,006
-88% -$9.26K ﹤0.01% 2498
2024
Q4 		$8.25K Buy
+9,117
New +$7.81K ﹤0.01% 1720

Other funds holding GOSS

D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
DIG
DeepCurrents Investment Group New York $3.3B AUM 12.57% 1-Year Est. Return
CCM
Context Capital Management Lajolla, California $5.15B AUM 1.28% 1-Year Est. Return
WVP
Worth Venture Partners Fort Lee, New Jersey $44.3M AUM 34.55% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $11.4B AUM 5.65% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
KCM
Kalehua Capital Management Dallas, Texas $174M AUM

SBI Securities's GOSS Position: Q2 2026 in Review

SBI Securities held its Gossamer Bio (GOSS) position steady in Q2 2026 at 614 shares worth $101. The position accounts for ﹤0.01% of the portfolio, ranked #3507.

SBI Securities first reported a position in GOSS in Q4 2024 and has held it in 7 quarters since. The position peaked at $13.7K in Q3 2025. 170 funds tracked by Wall St. Rank hold GOSS as of Q2 2026.

  • SBI Securities held 614 shares of Gossamer Bio worth $101 as of Q2 2026.
  • SBI Securities left its Gossamer Bio share count unchanged in Q2 2026.
  • Gossamer Bio made up ﹤0.01% of SBI Securities's portfolio in Q2 2026, its #3507 holding.
  • SBI Securities first reported a position in Gossamer Bio in Q4 2024 and has held it in 7 quarters since.
  • SBI Securities's Gossamer Bio position peaked at $13.7K in Q3 2025.
  • 170 funds tracked by Wall St. Rank held Gossamer Bio as of Q2 2026.

Based on SBI Securities's 13F filing for Q2 2026, filed 23 Jul 2026.